Sector
PharmaceuticalsOpen
₹524.5Prev. Close
₹521.7Turnover(Lac.)
₹417.65Day's High
₹536.5Day's Low
₹519.0552 Week's High
₹74552 Week's Low
₹312Book Value
₹143.29Face Value
₹5Mkt Cap (₹ Cr.)
1,681.33P/E
39.18EPS
13.59Divi. Yield
0.19Here are some of the stocks that may see significant price movement today: BHEL, IRCTC, Birlasoft, Bajaj Healthcare, etc.
Earlier this year, Bajaj Healthcare secured formal CMO agreements with customers in the United Kingdom and the European Union to deliver 15 APIs.
The strategic partnership aims to enhance Bajaj Healthcare's presence in the European pharmaceutical market.
Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 13.8 | 13.8 | 13.8 | 13.8 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 264.56 | 353.89 | 314.69 | 244.61 |
Net Worth | 278.36 | 367.69 | 328.49 | 258.41 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Revenue | 656.98 | 410 | 370.17 | 327.1 |
yoy growth (%) | 60.23 | 10.76 | 13.16 | 41.81 |
Raw materials | -377.89 | -263.23 | -242.02 | -215.28 |
As % of sales | 57.51 | 64.2 | 65.38 | 65.81 |
Employee costs | -34.54 | -28.43 | -24.61 | -21.65 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 118.81 | 32.45 | 24.16 | 22.68 |
Depreciation | -16.12 | -12.12 | -11.41 | -11.08 |
Tax paid | -35.71 | -9.95 | -7.85 | -7.49 |
Working capital | 78.78 | 14.98 | 9.66 | 26.86 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 60.23 | 10.76 | 13.16 | 41.81 |
Op profit growth | 184.93 | 12.24 | 8.66 | 27.97 |
EBIT growth | 226.77 | 20.85 | 6.55 | 39.23 |
Net profit growth | 269.37 | 37.94 | 7.4 | 94.08 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.6 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,484 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.1 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,164 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Sanjankumar R Bajaj
Managing Director
Anil C Jain
Whole-time Director
Namrata S Bajaj
Whole-time Director
Dhananjay S Halte
Independent Director
Ram B Banarase
Independent Director
Hemant R Karnik
Independent Director
Loukik D Tipnis
Independent Director
Kejal Shah
Whole-time Director
Pakshal Jain
Company Sec. & Compli. Officer
MONICA TANWAR
Independent Director
Sandeep Shah
Independent Director
Yaqoob Ali
602-606 Bhoomi Velocity Infote,
Road No 23 Wagle Indl Estate,
Maharashtra - 400604
Tel: 91-22-66177400/401
Website: http://www.bajajhealth.com
Email: investors@bajajhealth.com
Unit No 1 Luthra Ind,
Andheri Kurla Road, Safed Pool Andheri(E,
Mumbai - 400 072
Tel: 91-22-2851 5606
Website: www.sharexindia.com
Email: sharexndia@vsnl.com
Summary
Bajaj Healthcare Ltd. is a bulk drug manufacturer established in 1993, serving various Pharmaceuticals, Nutraceuticals and Food industries globally with a spirit of scrupulousness. The Company commenc...
Read More
Reports by Bajaj Healthcare Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.